Leishmania donovani causes visceral leishmaniasis (VL) by infecting the monocyte/macrophage lineage and residing inside specialized structures known as parasitophorous vacuoles. The protozoan parasite has adopted several means of escaping the host immune response, with one of the major methods being deactivation of host macrophages. Previous reports highlight dampened macrophage signaling, defective antigen presentation due to increased membrane fluidity, and the downregulation of several genes associated with L. donovani infection. We have reported previously that the defective antigen presentation in infected hamsters could be corrected by a single injection of a cholesterol-containing liposome. Here we show that cholesterol in the form of a liposomal formulation can stimulate the innate immune arm and reactivate macrophage function. Augmented levels of reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI), along with proinflammatory cytokines such as tumor necrosis factor alpha (TNF-␣) and interleukin 6 (IL-6), corroborate intracellular parasite killing. Cholesterol incorporation kinetics is favored in infected macrophages more than in normal macrophages. Such an enhanced cholesterol uptake is associated with preferential apoptosis of infected macrophages in an endoplasmic reticulum (ER) stress-dependent manner. All these events are coupled with mitogen-activated protein (MAP) kinase activation, while inhibition of such pathways resulted in increased parasite loads. Hence, liposomal cholesterol is a potential facilitator of the macrophage effector function in favor of the host, independently of the T-cell arm.
D
uring their intracellular life cycle, Leishmania parasites survive as obligate pathogens infecting the hematopoietic cells of the macrophage/monocyte lineage, which they enter by phagocytosis (1) . There they reside in specialized structures known as parasitophorous vacuoles at a low pH (2) . In order to escape the host immune response, leishmaniae have evolved some of the finest subversion mechanisms to dampen normal macrophage (M) function (3) .
The importance of cholesterol in the pathogenesis of visceral leishmaniasis (VL) is well established. Serum cholesterol content is found to be compromised in VL patients at the active stage of the disease and, more interestingly, bears an inverse correlation to splenic parasite loads (4) . The membrane cholesterol content was monitored and was found to be lowered under conditions of infection, resulting in the disruption of membrane rafts (5) . Membrane lipid rafts are microdomains consisting of cholesterol and sphingolipid that act as important pathogen portals (6) . Disruption of lipid rafts leads to defective antigen presentation (5) . This defect is corrected by liposomal delivery of cholesterol (5) , which also rectifies gamma interferon (IFN-␥) R1 and R2 dimerization (7) . In the experimental hamster model of VL, liposomal cholesterol administration rescued infected animals from organ parasite burdens (8) . The membrane cholesterol level was restored, with a concomitant increase in membrane rigidity. Studies performed on hypercholesterolemic mice showed that the cholesterol level was directly related to the severity of disease progression (9) . Interestingly, lipid metabolism was found to be drastically affected, and a liver microRNA, miR-122, was found to be actively involved (10) .
Cellular cholesterol content has widespread implications for macrophage function (11) . The accumulation of cholesterol derived from oxidized low-density lipoprotein (LDL) and acetylated LDL (Ac-LDL) in macrophages leads to characteristic foam cell formation (12) . Enhanced influx of cholesterol in macrophages induces the endoplasmic reticulum (ER) stress response (13, 14) by triggering intracellular calcium mobilization (15) . This event triggers the unfolded protein response (UPR) and results in macrophage apoptosis (16) . In this process, various signal transduction cascades are activated; one of the main signal transduction cascades is the mitogen-activated protein kinase (MAPK) pathway (17, 18) . Cholesterol-mediated apoptosis of macrophages works in a multifaceted way (19) . Both mitochondrial dysfunction, leading to the intrinsic route of apoptosis, and ER stresses, leading to the extrinsic route, have been reported (20) . A study suggests that negatively charged liposomes containing cholesterol and phosphatidylserine induce mitochondrion-mediated apoptotic events (20) . Moreover, there is evidence for the involvement of the Fas pathway in cholesterol-related macrophage apoptosis (20) .
Recently, it has been shown that serum cholesterol levels decreased at the active stage of kala azar but that all the lipid parameters returned to the normal reference range after successful chemotherapy (21) . Serum cholesterol is important in the regulation of cellular cholesterol (22) , and one-third of the cholesterol exchange between cells and serum occurs via non-receptor-mediated pathways (23) .
Liposomes are lipid vehicles that are very popular as model membranes (24) . They can act as long-circulating and efficient drugs or as gene delivery vehicles, or both. Recently they have been used as lipid carriers of drugs such as amphotericin B (25) . It is generally believed that cellular uptake of liposomes is mediated by adsorption of the liposome on the cell surface and subsequent endocytosis; the materials engulfed are processed by the endosomal lysosomal pathway (26) .
This study aims to dissect the innate immune arm of macrophages during Leishmania infection. Here we show that cholesterol is able to reactivate the deactivated macrophage, with subsequent generation of reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI) necessary for intracellular parasite killing. This is further supported by the production of proinflammatory cytokines that work in favor of the host. Additionally, induction of macrophage apoptosis through activation of MAP kinase acts as the last weapon to combat this deadly disease.
MATERIALS AND METHODS
Reagents and antibodies. RPMI 1640 and M-199 media, sodium bicarbonate, Giemsa stain, 2-mercaptoethanol (2-ME), tetramethylbenzidine (TMB), starch, the horseradish peroxidase (HRP)-conjugated anti-␤-actin antibody, agarose, N-acetylcysteine (NAC), and N G -monomethyl-Larginine acetate (L-NMMA) were purchased from Sigma-Aldrich (St. Louis, MO). Fetal calf serum (FCS) and a penicillin-streptomycin mixture were obtained from GIBCO, USA. Enzyme-linked immunosorbent assay (ELISA) kits for interleukin 6 (IL-6), IL-10, IL-12, and tumor necrosis factor alpha (TNF-␣) and the annexin V staining kit were purchased from BD Biosciences. Phosphatidylcholine (PC) (from egg lecithin) and 4-cholesten-3-one were purchased from ICN (Irvine, CA). Cholesterol, hydrogen peroxide, and Tween 20 were obtained from Merck. 25-{N-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)methyl]amino}-27-norcholesterol (25-NBD-cholesterol) was obtained from Avanti Polar Lipids. Griess reagent was purchased from Promega. U18666A [3␤-(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride] was from Biomol Research Laboratories, Inc. Acyl coenzyme A-cholesterol acyltransferase (ACAT) inhibitor 58035 {3-[decyldimethylsilyl]-N-[2-(4-methylphenyl)-1-phenylethyl] propanamide} was from Sandoz (East Hanover, NJ). SB203580, PD58059, and SP600125 were obtained from Calbiochem. Antibodies for phosphop38, p38, phosphorylated extracellular signal-regulated kinases 1 and 2 (phospho-ERK1/2), ERK1/2, phosphorylated Jun N-terminal protein kinases 1 and 2 (phospho-JNK1/2), and JNK were obtained from Cell Signaling. N,N,N=,N=-tetramethylethylenediamine (TEMED), Ponceau S, acrylamide, and bisacrylamide were from Merck, glycine from SRL Chemicals, and the SuperSignal West Pico enhanced chemiluminescent (ECL) substrate from Thermo Scientific. PageRuler protein markers were purchased from Fermentas Life Sciences.
Ethics statement. The use of mice was approved by the Institutional Animal Ethics Committee of the Indian Institute of Chemical Biology, India. All the experiments were performed according to the National Regulatory Guidelines issued by the Committee for the Purpose of Supervision of Experiments on Animals, Ministry of Environment and Forest, Government of India. All the experiments involving animals were carried out with the prior approval of the institutional animal ethics committee.
Animals. Adult BALB/c mice were collected from the animal house facility of the Indian Institute of Chemical Biology. They were kept under conventional conditions, with food and water provided ad libitum. They were used for experiments with prior approval of the institutional animal ethics committee.
Parasite maintenance. Golden hamsters (4 to 6 weeks old) were obtained from the animal facility of the Indian Institute of Chemical Biology. They were housed under conventional conditions, with food and water ad libitum, and were used for experimental purposes with prior approval of the institutional animal ethics committee. Leishmania donovani strain AG83 (MAOM/IN/1083/AG83), originally obtained from an Indian kalaazar patient, was maintained in golden hamsters. Amastigotes were isolated and were transformed to promastigotes for further use.
Isolation of PECs, in vitro infection, and parasite enumeration. Elicited peritoneal exudate cells (PECs) were isolated as described previously (27) and were kept in tissue culture plates for 48 h. PECs either were kept untreated or were infected with L. donovani promastigotes at a PEC/parasite ratio of 1:10. Six hours after addition, excess parasites were washed out, and cells were kept for 48 h in complete medium. Parasites were counted using a Giemsa staining protocol.
Cytokine assay. Supernatants from liposome-treated mouse macrophage (PEC) cultures were used to assay IL-6, IL-10, IL-12, and TNF-␣ by using the ELISA method according to the manufacturer's protocol.
Liposome preparation. Liposomes were prepared from PC and either cholesterol or its analogue (4-cholesten-3-one) at a molar ratio of 1:1.5 (28) . Briefly, 5.8 mg cholesterol or 4-cholesten-3-one and 8 mg PC were placed in chloroform, and a thin film was prepared; subsequently, it was placed in 1 ml RPMI 1640 medium and was sonicated (Microson Ultrasonic Cell Disruptor with 2 mm probe; Misonix) at 4°C three times, for 1 min each time, at maximum output (5) . A liposome prepared from cholesterol and PC was defined as a cholesterol-liposome. Similarly, a liposome prepared from 4-cholesten-3-one and PC was defined as an analogue-liposome.
NBD-cholesterol, the fluorescent analogue of cholesterol used to study cellular uptake, is believed to mimic the native orientation of cholesterol in the biomembrane (29) . Fluorescently labeled liposomes were prepared in order to study the transport of an imaging probe attached to cholesterol (NBD-cholesterol) and were introduced via liposomal formulations (29) . Initially, a stock solution of constituents was made in chloroform as follows: 50 ng/ml phosphatidylcholine, 100 mg/ml cholesterol, and 1 mg/ml NBD-cholesterol. Liposomes with cholesterol at a mole fraction of 0, 0.16, 0.33, 0.50, or 0.66, with the amount of PC kept fixed, and with NBD-cholesterol used at 1% of total cholesterol, were prepared by sonication in 1 ml RPMI 1640 medium as described in the preceding paragraph. For convenience, such liposomes are defined as NBD-liposomes. All liposomal formulations were checked for lipopolysaccharide (LPS) contamination by using endotoxin detection kits.
In vitro treatment of infected macrophages. PECs were isolated and infected according to the protocol described above. Cholesterol-liposomes were prepared as usual and were added at concentrations of 2, 4, 6, and 8 mol of total lipid/10 6 cells. An ACAT inhibitor was added at a concentration of 20 g/ml. Unless otherwise mentioned, "liposome" means a cholesterol-containing liposome plus ACAT inhibitor 58035 (Sandoz). Cells were treated with an inhibitor of the MAPK pathway ( Quantification of NO. NO production was evaluated by measuring the accumulation of nitrite in the culture medium by using Griess reagent (30) containing 1% sulfanilamide in 5% H 3 PO 4 and a 0.1% aqueous solution of N-1-naphthylethylene diamine hydrochloride. The mixture of Griess reagent and the culture supernatant at a 1:1 ratio was incubated for 15 min at room temperature in the dark, and the optical density (OD) was determined at 550 nm with a spectrophotometer (SmartSpec 3000; BioRad). Liposome-treated macrophage supernatants were collected at different time points. The culture supernatants were analyzed for their nitrite contents by using Griess reagent.
Measurement of ROS.
For monitoring the level of reactive oxygen species (ROS) (includes superoxide, hydrogen peroxide, and other reactive oxygen intermediates) produced within the cells, the cell-permeant nonpolar H 2 O 2 -sensitive probe 2=,7=-dichlorodihydrofluorescein diacetate (H 2 DCFDA) was used (31) . The extent of H 2 O 2 generation was defined as ROS generation for our convenience. Liposome-treated macro-phages were suspended in Hanks buffer and were incubated with H 2 DCFDA (2 g/ml) at room temperature for 20 min in the dark. Relative fluorescence was measured in a Perkin-Elmer LS50B spectrofluorometer at an excitation wavelength ( ex ) of 492 nm and an emission wavelength ( em ) of 535 nm. For each experiment, fluorometric measurements were performed in triplicate, and results were expressed in fluorescence intensity units.
Kinetics of the cellular uptake of cholesterol in terms of NBD-cholesterol in Ms. Mouse peritoneal macrophages either were left uninfected or were treated with stationary-phase Leishmania donovani strain AG83 at a cell/parasite ratio of 1:10. NBD-liposomes containing cholesterol at different molar ratios were added to the macrophages for different lengths of time, and the incorporation of NBD-cholesterol was studied by fluorescence-activated cell sorter (FACS) analysis. For this purpose, cells were washed three times with phosphate-buffered saline (PBS), and the relative level of NBD-cholesterol internalization was measured ( ex , 470 nm; em , 510 nm). The mean fluorescent intensities (MFI) were recorded and were plotted as a function of cholesterol concentration.
Annexin V-FITC staining for apoptosis study. Annexin V staining was carried out as described previously (13) . After the indicated treatment for the indicated lengths of time (see Results and figure legends), cells were washed once with PBS. Adherent cells were resuspended in 1 ml PBS and were pelleted down in the corresponding FACS tube. Annexin V-fluorescein isothiocyanate (FITC) staining was performed according to the manufacturer's protocol. Briefly, after washing, the pellet was resuspended in 100 l 1ϫ binding buffer. Five microliters of annexin V-FITC and 5 l of propidium iodide (PI) were added to the corresponding tubes. The tubes were tapped gently for proper mixing of the stains and were incubated at room temperature for 15 min in dark. Four hundred microliters of 1ϫ binding buffer was added, and analysis was carried out by flow cytometry.
Western blot analysis. The cell pellet was lysed in 1ϫ SDS dye containing 10% 2-ME and was separated on an 8-to-12% SDS-PAGE gel according to the different molecular weights of the proteins of interest by using 40 to 100 g of protein per sample. The proteins were transferred to a nitrocellulose membrane (Immobilon-P; 0.45 m; Millipore) in a wet transfer system (Bio-Rad) according to the manufacturer's instructions. The membrane was blocked in 3% bovine serum albumin (BSA) in Trisbuffered saline (TBS) containing 0.01% Tween 20 (TBST) for 1 h at room temperature with rocking. The membrane was blotted for different proteins at 4°C overnight (O/N) with rocking. Anti-phospho-p38, anti-p38, anti-phospho-ERK1/2, anti-ERK, anti-phospho JNK1/2, and anti-JNK (Cell Signaling Technology) were all used at a 1:1,000 dilution, and HRPconjugated anti-␤-actin (Sigma-Aldrich) was used at a 1:10,000 dilution. The membrane was further washed with 1ϫ TBST and was subsequently incubated with the HRP-conjugated secondary antibodies (anti-rabbit IgG and anti-mouse IgG from GE Healthcare), all at a dilution of 1:8,000 at room temperature for 1 h in a blocking buffer. The membrane was again washed and was developed using an ECL Western blot detection kit, and finally, bands were visualized with Vision Works Life Science software, version 6.80 (UVP). ␤-Actin was used as a normalizing control.
Statistical analysis. All experiments were carried out three times, and only representative data are presented, since interassay variation was within 5 to 10%. All micrographs were processed with Adobe Photoshop Elements, version 7. All graphs and statistical analyses were generated in GraphPad Prism, version 5.00 (GraphPad, San Diego, CA). A nonparametric unpaired t test was used for analysis. We considered P values of Ͻ0.05 to be statistically significant. These were classed as extremely significant (P, Ͻ0.001), very significant (P, 0.001 to 0.01), and significant (P, 0.01 to 0.05). P values of Ͼ0.05 were not considered significant. Error bars indicate means Ϯ standard errors of the means (SEM).
RESULTS

Kinetics of cholesterol incorporation in normal versus infected macrophages.
In order to follow membrane dynamics in infection, we studied the kinetics of incorporation of NBD-cholesterol into normal and Leishmania donovani-infected macrophages as a function of liposomal cholesterol concentration. It was observed that both normal and infected macrophages take up NBD-cholesterol from the liposomal formulation and that the rate of incorporation increases steadily with the mole fraction of cholesterol content in the liposomes. Interestingly, it was found that infected macrophages could take up more NBD-cholesterol than their normal counterparts, which was significantly reflected at 0.33 to 0.5 mole fractions of cholesterol and at 120 min postincubation ( Liposomal cholesterol induces intracellular parasite killing. Infected macrophages were treated with cholesterol-containing liposomes at varying concentrations (2, 4, 6, and 8 mol of total lipid/10 6 cells) for 24 h. Both normal and infected macrophages were checked for viability, which was slightly reduced upon liposome addition (see Fig. S1 in the supplemental material). Macrophages were fixed, and the percentages of viable infected macrophages and intracellular parasites were determined. The percentage of infected macrophages was reduced from 85% to 62%, 44%, 23%, or 12% with 2, 4, 6, or 8 mol of total lipid/10 6 cells, respectively (see Fig. S4A in the supplemental material). This was also reflected in the number of parasites/100 macrophages, which dropped from 450 to 400, 350, 200, or 120, respectively (see Fig.  S4B in the supplemental material). At concentrations as high as 6 mol of total lipid/10 6 cells, the cells were apparently healthy, but at 8 mol of total lipid/10 6 cells, they showed necrotic properties, with distinct deformities. Hence, subsequent experiments were performed with 6 mol of total lipid/10 6 cells. When a time kinetics experiment was performed, the percentage of infection was reduced from 82% to 54% with a 12-h treatment and continued to decrease sharply with time, reaching approximately 3% at the 48-h treatment point (Fig. 2A) . The numbers of parasites per 100 macrophages corroborated this trend well (Fig. 2B) . Representative Giemsa-stained pictures are shown in Fig. S5 in the supplemental material.
To show that the effect was cholesterol specific, we used various controls (see Fig. S3 in the supplemental material) . First, liposomes prepared with phosphatidylcholine alone failed to offer protection. When 4-cholesten-3-one (an analogue of cholesterol) was used instead of cholesterol in a similar quantum, the reduction of the parasite load was insignificant. We used an ACAT inhibitor (58035) along with a cholesterol-containing liposome to restrict cholesterol esterification and observed that this combination was more effective in parasite killing (reducing the percentage of infected macrophages to 27% from 82%) than a cholesterolcontaining liposome alone (reduction to 40% from 82%). Another very interesting control was related to cholesterol transport. U16888A, a pharmaceutical blocker of ER cholesterol transport (15) , showed almost 90% inhibition of parasite killing when used at a 20 M concentration.
Cholesterol-containing liposomes induce macrophage effector function. ROS generation was evident in both normal and infected macrophages and increased gradually with increasing liposome concentrations up to 6 mol/10 6 cells at 12 h posttreatment (see Fig. S6A in the supplemental material) . A time-dependent study with a concentration of 6 mol/10 6 cells showed that ROS generation was enhanced in both normal and L. donovaniinfected macrophages. A peak was attained at 12 h and declined thereafter (Fig. 3A) .
Similarly, nitric oxide production in liposome-treated cell supernatants was monitored at different times. NO production was observed at nonsignificant levels in normal and infected macrophages but gradually increased with liposome treatment. At 6 mol of total lipid/10 6 cells, NO generation reached a maximum, which decreased suddenly at higher concentrations due to cell death (see Fig. S6B in the supplemental material). Time kinetics showed a peak at 24 h, after which levels started to decrease (Fig. 3B) .
To ascertain that ROS and NO are indeed involved in the killing of L. donovani, infected Ms were treated with NAC, a potent scavenger of ROS, and L-NMMA, a competitive inhibitor of inducible NO synthase (iNOS), 1 h prior to liposome treatment. Pretreatment with NAC significantly inhibited parasite killing mediated by cholesterol-containing liposomes (P, Ͻ0.001 for 8 h and Ͻ0.005 for 12 h and 24 h) relative to levels for corresponding cholesterol-containing liposome-treated controls (Fig. 3C) . Pretreatment with L-NMMA significantly inhibited cholesterol-containing liposome-mediated parasite killing (P, Ͻ0.001 for all time points) relative to levels for corresponding cholesterol-containing liposome-treated controls (Fig. 3D) . Interestingly, when the NAC and L-NMMA treatments were combined, enhanced inhibition of parasite killing was observed, showing a slight synergy in the action of ROS and NO on intracellular killing (Fig. 3E) .
Cholesterol-containing liposomes induce preferential apoptosis in parasitized macrophages. Unesterified cholesterol leads to the ER stress response, forming characteristic foam cells, which ultimately lead to macrophage apoptosis (19) . On the other hand, L. donovani infection is known to inhibit macrophage apoptosis (32) for the purpose of survival in the parasitophorous vacuole. It is of special interest to investigate the role of cholesterol in the apoptosis of L. donovani-infected macrophages.
For this purpose, normal and L. donovani-infected macrophages were treated with cholesterol-containing liposomes plus ACAT inhibitor 58035, and apoptosis was monitored using annexin V staining as an early apoptosis marker. FACS analysis was carried out for annexin V-positive, PI-negative cells (to exclude necrotic cells), and the percentage of apoptotic cells was determined.
Normal uninfected cells showed 11.7% annexin V-positive cells. Upon infection, this proportion was reduced to 10.2%, but it increased upon treatment with cholesterol-containing liposomes. The percentage of apoptotic cells increased from 17.2% to 18.5% and 24.5% for 2, 4, and 6 mol/10 6 cells, respectively. At 8 mol/ 10 6 cells, almost 85.6% of cells were apoptotic and 7.18% were PI positive (see Fig. S7 in the supplemental material). In order to see if there was any differential effect of cholesterol-containing liposomes on normal and infected macrophages, we treated them both with 6 mol/10 6 cells. Interestingly, normal macrophages showed only a 20% increase in apoptosis (from 15.7% to 18.4%), whereas infected macrophages showed an increase as high as 100%, i.e., almost twice as many infected macrophages as in the no-liposome control cells (from 12.9% to 24.3%) (Fig. 4) .
Interestingly, the addition of U16888A (an ER cholesterol transport blocker) along with cholesterol-containing liposomes results in inhibition of apoptosis (from 18.4% to 16% and from 24.3% to 19.9% for normal and infected macrophages, respectively) (Fig. 4) . This serves as additional proof of a cholesterolspecific apoptotic event working preferentially in parasitized macrophages.
Reactive oxygen species production, but not nitric oxide generation, is required for ER stress-induced apoptosis in infected macrophages. Effector molecules such as ROS and NO are known to induce apoptosis (33) . Here we tried to investigate the dependency of ER stress-induced apoptosis on ROS and NO in mouse macrophages treated with cholesterol-containing liposomes. ROS generation was blocked using NAC, a ROS scavenger, and it was found that the percentage of apoptotic cells was reduced from 24.7% for liposome-treated macrophages to 17.2% for NAC-pretreated macrophages. However, blocking NO production resulted in 20.4% apoptotic cells (Fig. 5) .
Inhibiting JNK II but not p38 MAPK or ERK1/2 rescues parasitized macrophages from cholesterol-mediated apoptosis. It is already known that L. donovani evades the activation of the MAP kinase pathway during the process of infection of naïve macrophages (3) . Cholesterol, on the other hand, is known to activate the MAP kinase cascade by phosphorylating p38, ERK1/2, and JNK II (34) . These previous reports led us to investigate the possibility of the involvement of MAP kinase in the cholesterol-mediated apoptosis of L. donovani-infected macrophages.
We used inhibitors of p38, ERK1/2, and JNK II while scoring annexin V-positive, PI-negative cells. When the JNK II inhibitor SP600125 was used along with cholesterol-containing liposomes plus an ACAT inhibitor, the percentage of apoptotic cells was reduced to 14.3% from 24.3% in the absence of the inhibitor, while 12.9% of infected control cells were apoptotic. Surprisingly, the p38 inhibitor SB203580 and the ERK1/2 inhibitor PD98059 could change the percentage of apoptosis only to 21.9% and 23.5%, respectively, an effect that is very insignificant in comparison to that of cholesterol-liposome treatment (Fig. 6) . From this picture, it could be inferred that JNK II is specifically involved in cholesterol-mediated macrophage apoptosis under parasitized conditions. Activation of MAP kinase causes the generation of effector molecules for parasite killing. The induction of various microbicidal mechanisms is known to involve the activation of MAP kinase pathways (35) . Western blot analysis was performed for p38, ERK1/2, and JNK 1/2 and their phosphorylated forms. All three MAP kinases were activated, as evidenced by their phosphoryla- tion status (Fig. 7A) . p38 was activated at 1 h treatment and remained activated till 12 h. ERK1/2 showed a basal level of phosphorylation, strongest at 2 h of treatment and returning to the normal level after 8 h. JNK1/2 was activated at 2 h; activation was enhanced at 4 h and declined thereafter.
Direct evidence for the involvement of MAP kinase activation was found by enumeration of intracellular parasites in the presence and absence of pharmaceutical inhibitors of MAP kinase ( Fig. 7B and C) . Treatment with cholesterol-containing liposomes reduced the parasite load from 82% to 22% at 6 mol total lipid/ 10 6 cells. Upon the addition of p38 and ERK1/2 inhibitors, the parasite load increased to around 60%, while blocking JNK resulted in only 45% infection. When combinations of inhibitors were added, stronger effects were visible. SB203580 (p38 inhibitor) plus PD58059 (ERK1/2 inhibitor) showed around 70% infection. SB203580 or PD58059, when added individually along with SP600125 (JNK II inhibitor), showed around 60 to 70% infection. Most remarkably, when all the inhibitors were added simultaneously along with cholesterol-containing liposomes, there was a total blockage of parasite killing (approximately 80% infection).
Similar experiments were conducted with these inhibitors, and the production of ROS and NO was determined. ERK1/2 and p38 inhibitors showed direct reductions in ROS and NO generation, respectively. Neither SB203580 nor SP600125 showed any reduction in ROS generation (Fig. 7D) . Again, PD58059 and SP600125 failed to affect NO generation (Fig. 7E) . These results prove directly the selective role of ERK1/2 and p38 activation in ROS and NO generation, leading to parasite killing. The mechanism of action of JNK is different, probably the induction of preferential apoptosis of parasitized macrophages. Proinflammatory cytokines such as IL-6 and TNF-␣ show a significant surge upon treatment with cholesterol-containing liposomes. The statuses of various pro-and anti-inflammatory cytokines commonly secreted by macrophages were determined (Fig. 8) . Upon infection, TNF-␣ showed an increase in the basal level over that in normal macrophages, and expression increased gradually with liposome treatment (P, Ͻ0.001, Ͻ0.0001, and Ͻ0.001 for 2, 4, and 6 mol/10 6 cells). A sudden rise in the IL-6 level was observed at 2 mol/10 6 cells; this level reached its peak at 4 mol/10 6 cells and started declining at 6 mol/10 6 cells. For IL-12, significant changes were observed only at 4 mol/10 6 cells. On the other hand, IL-10 showed a remarkable surge for infected macrophages. Upon liposome treatment, IL-10 production was greatly reduced for all concentration ranges. It is noteworthy that even in normal macrophages, increases in the levels of IL-6 and TNF-␣ were observed upon treatment with cholesterol-containing liposomes, although IL-10 and IL-12 showed no significant differences between normal and infected macrophages. Hence, a cytokine milieu favorable toward parasite killing is established, mediated by cholesterol delivery via liposomal formulation.
DISCUSSION
Pharmacokinetic analysis of liposome uptake suggests very different patterns of distribution in vivo and in vitro (36) . The use of NBD-cholesterol in cellular incorporation studies is well documented (37) . Upon deliberate infection, mouse macrophages show properties of increased cholesterol uptake as early as 30 min. Interestingly, biophysical kinetic data suggest an enhanced capacity for liposomal uptake by infected macrophages.
Reactive oxygen species and nitric oxide are two potent microbicidal molecules recognized for their efficacy against Leishmania parasites (31, 38) . Inhibition of NO production or of ROS generation can lead to uncontrolled infection (39) . Previously, it was reported that LDL and UV-oxidized LDL can induce the upregulation of iNOS and NO in macrophages (40) . A previous study from our laboratory showed that treatment of L. donovani-infected murine macrophages with sodium antimony gluconate (SAG) can induce ROS and NO generation, where ROS-mediated killing is predominantly an early event while NO operates at late hours of treatment (41) . We quantified NO generation in normal, infected, and liposome-treated macrophages and found enhanced NO production due to a nonlipoprotein cholesterol source. Again, in the presence of L-NMMA, a competitive inhibitor of iNOS, cholesterol-containing liposomes failed to show intracellular parasite killing, proving the requirement for NO production in infection control. Similarly, cholesterol-containing liposomes induce ROS generation, which also contributes to parasite killing. This ROS-mediated antimicrobial effect is hindered by NAC, a ROS scavenger. Interestingly, simultaneous addition of NAC and L-NMMA could show only a slight synergy. This can be explained by different time windows of ROS and NO action on infected macrophages. These results are in agreement with the previous finding that cholesterol loading augments oxidative stress in macrophages (42) . Repression of cytokine production, particularly of those cytokines involved in the inflammatory response (TNF-␣, IL-6, IL-12), is another mechanism of subversion (3, 43) . It is worth mentioning that both TNF-␣ and IL-6 show significant surges upon the addition of cholesterol-containing liposomes under parasitized conditions, a finding in agreement with a report that macro- phages loaded with free cholesterol (Ac-LDL plus ACAT inhibitor 58305) are abundant sources of TNF-␣ and IL-6 (44) . In this context, it should be mentioned that L. donovani infection suppresses Toll-like receptor 2 (TLR2)-mediated IL-12p40 expression, with an increase in IL-10 production (45) . Complete reversal of this phenotype, i.e., augmentation of IL-12 production, with a simultaneous reduction in IL-10 production, is stimulated by cholesterol-containing liposomes. How TLR2 (or any other TLR) is involved in this mechanism is worth exploring.
At this point, the destructive effect of cholesterol on parasite survival has been investigated. The other arm of the ongoing research aims to elucidate the fate of host macrophages upon liposome treatment. This is of particular importance for understanding the full spectrum of action of cholesterol-containing liposomes on the Leishmania-macrophage interaction. Intracellular protozoan parasites have been reported to inhibit the apoptotic program of the host (46) . Intramacrophage infection by L. donovani results in increased viability of the host cell (32) .
In another section of macrophage research, oriented toward atherosclerosis, several studies suggest that the accumulation of intracellular-lipoprotein-derived free cholesterol can adversely affect M viability (47, 48) .
The key event underlying cholesterol-induced macrophage death is depletion of ER calcium stores and subsequent activation 6 cells) plus 20 g/ml of 58035 (ACAT inhibitor) or combinations of two or three inhibitors at a time. Giemsa staining was carried out, and parasites were enumerated as usual. (D and E) Infected macrophages were treated as described above, and ROS (D) and NO (E) production were determined as usual. Data represent means Ϯ SEM for three independent experiments. ***, P Ͻ 0.001; **, P Ͻ 0.01; *, P Ͻ 0.05. of the unfolded protein response (UPR). But in advanced atherosclerosis, a deficiency of ACAT activity results in further cholesterol accumulation and induction of macrophage apoptosis by ER stress (49, 50) .
On joining these two arms, some questions arise. How do parasitized macrophages handle this excess cholesterol? Does M apoptosis help in parasite clearance? Can cholesterol-containing liposomes reverse the L. donovani-induced inhibition of macrophage apoptosis?
Annexin V staining revealed that infected macrophages undergo preferential cell death upon exposure to cholesterol-containing liposomes, which might have a beneficial role in parasite clearance and host protection. Again, the PC present in the liposome may inhibit instantaneous cholesterol-induced necrosis (51) . The specificity of cholesterol and the involvement of ER stress were authenticated by the use of U16888A, which prevented cholesterol-induced apoptosis.
Investigation using NAC and L-NMMA revealed that blocking ROS, but not NO, inhibited cholesterol-induced, ER stress-dependent apoptosis. This is in agreement with previous reports that in Toxoplasma gondii infection, ROS-triggered trophoblast apoptosis is initiated by ER stress via activation of the JNK pathway along with caspase-12 and CHOP (52) . A study demonstrated that fenretinide, a synthetic retinoid with antitumor activity, induced PLAB protein upregulation involving ROS generation, ER stress induction, and JNK activation (53) . The role of ROS in TNFinduced apoptosis is also well known (54). Here we report that a cholesterol-containing liposomal formulation works in a similar way, leading to preferential apoptosis of infected macrophages, which may be an indirect consequence of ROS induction.
Impairment of host cell signaling is one of the key weapons of the protozoan parasite against host Ms (3). MAP kinase activation is heavily linked to any microbicidal effects by upregulation of the NF-B pathway (55) . L. donovani promastigotes are known to evade the activation of p38, ERK1/2, and JNK1/2 (56). The activation of phosphotyrosine phosphatase attenuates MAP kinase signaling and inhibits c-Fos and iNOS expression in infected macrophages (57, 58) . Activation of p38 attenuates L. donovani infection (59) . Again, cholesterol accumulation is linked to activation of MAP kinase cascades (34, 44) , whereas M apoptosis involves the requirement of p38 and JNK activation. When apoptotic events were monitored in the presence of the inhibitors of MAP kinase activation, the maximum reduction in apoptosis was experienced with the JNK 2 inhibitor (SP600125). A previous report states that free-cholesterol-induced macrophage apoptosis is mediated by inositol-requiring enzyme 1 alpha-regulated activation of Jun N-terminal kinase (18) . Chandra and Naik showed that L. donovani modulates the TLR2-mediated MAP kinase pathway (45) . Activation of TLR2, if any, by cholesterol may lead to phosphorylation of p38 MAPK, ERK1/2, and JNK1/2. The phosphorylation statuses of all three MAPKs were determined, and quite interestingly, all were phosphorylated, with minor alterations in the time window of activation. As an additional support, parasite clearance was strongly hampered in the presence of the MAPK inhibitors. Interestingly, NO and ROS generation was dampened with p38 and ERK1/2 inhibitors, respectively, in agreement with our previous study, where SAG-induced production of ROS and NO was prevented by ERK1/2 and p38 inhibitors (41) . Hence, in conclusion, it could be said that various phenomena are orchestrated; an intricate network of events, including cholesterol-containing liposome-mediated apoptosis, the ER stress response, and MAP kinase activation, resulting in the generation of ROS and NO and stimulating proinflammatory cytokine production, ultimately aims at clearing intracellular parasites, leading to host protection.
